Expanding the medicinally relevant chemical space with compound libraries

Drug Discovery Today

Volumn 17, Issue 13-14, 2012, Pages 718-726

  López Vallejo, Fabian ^a   Giulianotti, Marc A ^a   Houghten, Richard A ^a   Medina Franco, José L ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CHEMICAL COMPOUND; NATURAL PRODUCT;

CHEMISTRY; CHINESE MEDICINE; CHIRALITY; COMPOUND LIBRARY; DATA BASE; DRUG MARKETING; HIGH THROUGHPUT SCREENING; LIBRARY; MOLECULE; PHYSICAL CHEMISTRY; REVIEW; STEREOCHEMISTRY;

BIOLOGICAL PRODUCTS; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; MEDICINE, CHINESE TRADITIONAL; MOLECULAR CONFORMATION; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84863512122     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.04.001     Document Type: Review

References (47)

1. C.A. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
2. B. Faller Evolution of the physicochemical properties of marketed drugs: can history foretell the future? Drug Discov. Today 16 2011 976 984
3. P.D. Leeson, and A.M. Davis Time-related differences in the physical property profiles of oral drugs J. Med. Chem. 47 2004 6338 6348 (Pubitemid 39587257)
4. H. Zhao Lead optimization in the nondrug-like space Drug Discov. Today 16 2011 158 163
5. J. Hert Quantifying biogenic bias in screening libraries Nat. Chem. Biol. 5 2009 479 483
6. S. Dandapani, and L.A. Marcaurelle Accessing new chemical space for 'undruggable' targets Nat. Chem. Biol. 6 2010 861 863
7. J.M. Foulks Epigenetic drug discovery J. Biomol. Screening 17 2012 2 17
8. J.L. Medina-Franco, and T. Caulfield Advances in the computational development of DNA methyltransferase inhibitors Drug Discov. Today 16 2011 418 425
9. D.H. Drewry, and R. Macarron Enhancements of screening collections to address areas of unmet medical need: an industry perspective Curr. Opin. Chem. Biol. 14 2010 289 298
10. P. Selzer Complex molecules: do they add value? Curr. Opin. Chem. Biol. 9 2005 310 316 (Pubitemid 40804555)
11. F. Lovering Escape from flatland: increasing saturation as an approach to improving clinical success J. Med. Chem. 52 2009 6752 6756
12. P.A. Clemons Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles Proc. Natl. Acad. Sci. U. S. A. 107 2010 18787 18792
13. M.M. Hann Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Comput. Sci. 41 2001 856 864
14. A.R. Leach, and M.M. Hann Molecular complexity and fragment-based drug discovery: ten years on Curr. Opin. Chem. Biol. 15 2011 489 496
15. H. Chen A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds MedChemComm 3 2012 312 321
16. G.L. Thomas, and C.W. Johannes Natural product-like synthetic libraries Curr. Opin. Chem. Biol. 15 2011 516 522
17. R.A. Houghten Mixture-based synthetic combinatorial libraries J. Med. Chem. 42 1999 3743 3778 (Pubitemid 29453457)
18. R.A. Houghten Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing, in vivo, and enhanced deconvolution by computational methods J. Comb. Chem. 10 2008 3 19
19. J.P. Kennedy Application of combinatorial chemistry science on modern drug discovery J. Comb. Chem. 10 2008 345 354
20. C. Pinilla Advances in the use of synthetic combinatorial chemistry: mixture-based libraries Nat. Med. 9 2003 118 122 (Pubitemid 36098272)
21. F. López-Vallejo Integrating virtual screening and combinatorial chemistry for accelerated drug discovery Comb. Chem. High Throughput Screen. 14 2011 475 487
22. N. Singh Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository J. Chem. Inf. Model. 49 2009 1010 1024
23. F. López-Vallejo Increased diversity of libraries from libraries: chemoinformatic analysis of bis-diazacyclic libraries Chem. Biol. Drug Des. 77 2011 328 342
24. J.R. Owen Visualization of molecular fingerprints J. Chem. Inf. Model. 51 2011 1552 1563
25. C.Y-C. Chen TCM Database@Taiwan: the world's largest traditional chinese medicine database for drug screening in silico PLoS ONE 6 2011 862 868
26. D.K. Agrafiotis A constant time algorithm for estimating the diversity of large chemical libraries J. Chem. Inf. Comput. Sci. 41 2001 159 167 (Pubitemid 33645685)
27. Molecular Operating Environment (MOE), version 2010.10; Chemical Computing Group Inc., Montreal, Quebec, Canada
28. J.J. Irwin, and B.K. Shoichet ZINC - a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 45 2005 177 182 (Pubitemid 40736970)
29. D.S. Wishart DrugBank: a knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res. 36 2008 D901 D910
30. S.H. Bertz The 1st general index of molecular complexity J. Am. Chem. Soc. 103 1981 3599 3601
31. R. Barone, and M. Chanon A new and simple approach to chemical complexity. Application to the synthesis of natural products J. Chem. Inf. Comput. Sci. 41 2001 269 272 (Pubitemid 32408637)
32. T.K. Allu, and T.I. Oprea Rapid evaluation of synthetic and molecular complexity for in silico chemistry J. Chem. Inf. Model. 45 2005 1237 1243 (Pubitemid 41476007)
33. A. Schuffenhauer Relationships between molecular complexity, biological activity, and structural diversity J. Chem. Inf. Model. 46 2006 525 535
34. Maestro, version 9.2 2011 Schrödinger, LLC
35. D.F. Veber Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 45 2002 2615 2623 (Pubitemid 34595232)
36. A. Ganesan The impact of natural products upon modern drug discovery Curr. Opin. Chem. Biol. 12 2008 306 317
37. T. Fink, and J-L. Reymond Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery J. Chem. Inf. Model. 47 2007 342 353 (Pubitemid 46615939)
38. F. López-Vallejo Benzotriazoles and indazoles are scaffolds with biological activity against Entamoeba histolytica J. Biomol. Screening 16 2011 862 868
39. A. Yongye Consensus models of activity landscapes with multiple chemical, conformer and property representations J. Chem. Inf. Model. 51 2011 1259 1270
40. J.L. Medina-Franco Consensus models of activity landscapes D. Matthias, Statistical Modeling of Molecular Descriptors in QSAR/QSPR 2012 Wiley-VCH 307L 326
41. J.L. Medina-Franco A similarity-based data-fusion approach to the visual characterization and comparison of compound databases Chem. Biol. Drug Des. 70 2007 393 412 (Pubitemid 47609964)
42. J.L. Medina-Franco Visualization of the chemical space in drug discovery Curr. Comput.-Aided Drug Des. 4 2008 322 333
43. L.B. Akella, and D. DeCaprio Cheminformatics approaches to analyse diversity in compound screening libraries Curr. Opin. Chem. Biol. 14 2010 325 330
44. J.L. Medina-Franco Characterization of activity landscapes using 2D and 3D similarity methods: consensus activity cliffs J. Chem. Inf. Model. 49 2009 477 491
45. J. Pérez-Villanueva Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives Biorg. Med. Chem. 18 2010 7380 7391
46. J. Yoo, and J.L. Medina-Franco Chemoinformatic approaches for inhibitors of DNA methyltransferases: comprehensive characterization of screening libraries Comput. Mol. Biosci. 1 2011 7 16
47. T.J. Ritchie The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types Drug Discov. Today 16 2011 164 171